Dasotraline Completed Phase 3 Trials for Binge Eating Disorder (BED) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02684279Dasotraline Binge Eating Disorder Extension Study
NCT03107026A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder